Recent advances in the treatment of systemic sclerosis associated interstitial lung disease

HIGHLIGHTS

• who: ufeffAntoniyaufeff ufeffKamenovaufeff from the National Institute of Respiratory DiseasesMexico (INER) have published the research: Recent advances in the treatment of systemic sclerosis associated interstitial lung disease, in the Journal: (JOURNAL)

SUMMARY

This review will focus on the pathogenesis of CTD-ILD, particularly SSc-ILD which is more commonly associated with ILD than other CTDs, and summarize the recent evidence from clinical trials. frontiersin.org 10.3389/fmed.2023.1155771 2. The next development in the treatment options for SSc-ILD came from the SENSCIS (Safety and Efficacy of Nintedanib in Systemic Sclerosis . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.